Updates on Compulsory Registration for Class C and D Medical Devices
Introduction:
In a significant regulatory shift, the Central Drugs Standard Control Organization (CDSCO) is set to revamp the compliance landscape for Class C and Class D (non-notified) medical devices, effective from October 1, 2023. The traditional mandatory registration process is making way for a more streamlined licensing system, in accordance with GSR 102(E) dated 11.02.2020. This article provides a comprehensive overview of these updates and what they mean for manufacturers and importers in the medical device industry.
Understanding the Regulatory Evolution:
Under the new licensing paradigm, manufacturers and importers must align with the Medical Devices Rules (MDR) 2017 while utilizing CDSCO's online portal for application submissions. This transition not only promises greater efficiency but also a significant reduction in paperwork. However, it is imperative that stakeholders remain diligent in preparing comprehensive documentation and complying with prescribed fees to expedite the licensing process.
Embracing Collaborative Progress:
As these changes take root, it's essential for industry stakeholders, including associations and regulatory bodies, to collaborate effectively. By working together, they can ensure a seamless transition and support the development of a more streamlined and resilient regulatory framework for the future.
Conclusion:
The shift from compulsory registration to a licensing system for Class C and Class D medical devices marks a pivotal moment in the industry's evolution. Manufacturers and importers must prepare for this regulatory transformation by understanding the new requirements and compliance procedures. As the industry adapts, a cooperative approach among all stakeholders will be vital in paving the way for a more efficient and responsive regulatory environment.
For expert guidance on navigating the changing regulatory landscape for Class C and Class D medical devices, reach out to Operon Strategist today.














